Reuters
27 Apr 2026, 11:16 UTC · 24w ago
Verdict
Headline takes no side. We score ORKA +1.00 — strongly bullish.
+1.00strongly bullish
More positive than 99% of ticker scores this week
Scored by the NIS engine · methodology.
Top 1 mover · tap to explore
Which stocks this story touches
More positive than 99% of ticker scores this week
The company's experimental drug met its main goal in a mid-stage study, causing shares to surge 43.4%.
Continue reading
5 related stories
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Reuters
1d ago
+4.2%
Price agrees with the score
$71.93 vs $69.03 close before publication (Apr 24) · not market-adjusted
ORKA chart →
